Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed: 2013-2025

Historic Return on Capital Employed for Ptc Therapeutics (PTCT) over the last 12 years, with Sep 2025 value amounting to 0.44%.

  • Ptc Therapeutics' Return on Capital Employed rose 54.00% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 54.00%. This contributed to the annual value of -0.25% for FY2024, which is 12.00% up from last year.
  • Ptc Therapeutics' Return on Capital Employed amounted to 0.44% in Q3 2025, which was up 22.89% from 0.36% recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Return on Capital Employed high stood at 0.45% for Q1 2025, and its period low was -0.80% during Q3 2023.
  • For the 3-year period, Ptc Therapeutics' Return on Capital Employed averaged around -0.16%, with its median value being -0.25% (2024).
  • Per our database at Business Quant, Ptc Therapeutics' Return on Capital Employed crashed by 54bps in 2023 and then skyrocketed by 74bps in 2025.
  • Quarterly analysis of 5 years shows Ptc Therapeutics' Return on Capital Employed stood at -0.26% in 2021, then dropped by 11bps to -0.36% in 2022, then fell by 9bps to -0.45% in 2023, then climbed by 20bps to -0.25% in 2024, then soared by 54bps to 0.44% in 2025.
  • Its Return on Capital Employed was 0.44% in Q3 2025, compared to 0.36% in Q2 2025 and 0.45% in Q1 2025.